FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Newsome, Philip N; Sasso, Magali; Deeks, Jonathan J; Paredes, Angelo; Boursier, Jérôme; Chan, Wah-Kheong; Yilmaz, Yusuf; Czernichow, Sébastien; Zheng, Ming-Hua; Wong, Vincent Wai-Sun; Allison, Michael; Tsochatzis, Emmanuel; Anstee, Quentin M; Sheridan, David A; Eddowes, Peter J; Guha, Indra N; Cobbold, Jeremy F; Paradis, Valérie; Bedossa, Pierre; Miette, Véronique; Fournier-Poizat, Céline; Sandrin, Laurent; Harrison, Stephen A

doi:10.1016/S2468-1253(19)30383-8

All Outputs (2)

Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis (2020)
Journal Article

Background & Aims Serum alkaline phosphatase (ALP) and the enhanced liver fibrosis (ELF) score are used as endpoints in trials of patients with primary sclerosing cholangitis (PSC). We aimed to quantify inter- and intra-individual variation in level... Read More about Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study (2020)
Journal Article

Background The burden of non-alcoholic fatty liver disease (NAFLD) is increasing globally, and a major priority is to identify patients with non-alcoholic steatohepatitis (NASH) who are at greater risk of progression to cirrhosis, and who will be ca... Read More about FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.